Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy

Dig Dis Sci. 2015 Nov;60(11):3226-9. doi: 10.1007/s10620-015-3640-x. Epub 2015 Apr 1.

Authors

Thuy B Tran¹, Chinmaya K Bal¹, Kurt Schaberg², Teri A Longacre², Bhupinder S Chatrath³, George A Poultsides⁴

Affiliations

¹ Department of Surgery, Stanford University School of Medicine, 300 Pasteur Drive, Suite H3680D, Stanford, CA, 94305, USA.
² Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
³ Department of Medicine, Sequoia Regional Cancer Center, Visalia, CA, USA.
⁴ Department of Surgery, Stanford University School of Medicine, 300 Pasteur Drive, Suite H3680D, Stanford, CA, 94305, USA. gpoultsides@stanford.edu.

PMID: 25824976
DOI: 10.1007/s10620-015-3640-x

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bile Duct Neoplasms / pathology
Bile Duct Neoplasms / therapy*
Biopsy
Chemotherapy, Adjuvant
Cholangiocarcinoma / pathology
Cholangiocarcinoma / therapy*
Cisplatin / therapeutic use
Deoxycytidine / analogs & derivatives
Deoxycytidine / therapeutic use
Gemcitabine
Hepatectomy / methods*
Humans
Male
Neoadjuvant Therapy*
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Tumor Burden

Substances

Deoxycytidine
Cisplatin
Gemcitabine